WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 17, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a Virtual Life Science Event for the investment community on Thursday, December 10 at 8:30 a.m. ET. This event is organized to serve as an in-depth breakdown of the... Read more
WASHINGTON, Nov. 16, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Wolfe Research Healthcare Conference on Thursday, November 19, 2020 at 12:00 p.m. ET. The audio will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a global science and technology innovator... Read more
CHELMSFORD, Mass., Nov. 16, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in Stephens Annual Investment Conference 2020 on Thursday, November 19, 2020 which includes a 45-minute webcast beginning at 9:00 a.m. ET. The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. A replay... Read more
Germantown, Maryland, and Hilden, Germany, November 16, 2020 –QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that will help healthcare professionals quickly identify and differentiate between patients with common seasonal respiratory infections and COVID-19. With the Northern Hemisphere in the grip of flu... Read more
LC 300TM platform and SimplicityChromTM software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance Waltham, Mass. – November 16, 2020 – PerkinElmer, Inc., today introduced the LC 300TM platform and SimplicityChromTM software, bringing together advanced high-performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography (UHPLC) capabilities with intuitive instrument control and... Read more
The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Roche performed particularly well in Marketing Practices, Environmental and Social Reporting, Operational Eco-Efficiency, Climate Strategy, and Corporate Citizenship and Philanthropy Basel, 16 November 2020 – For the eleventh time, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised as the... Read more
One-dose, oral Xofluza has been recommended for approval for the treatment of uncomplicated influenza in patients aged 12 years and above Xofluza has also been recommended for approval as a preventive treatment (post-exposure prophylaxis) of influenza in individuals aged 12 years and above If approved, Xofluza would be the first innovation in mode of action... Read more
Phesgo offers faster and less invasive delivery of standard of care treatment with Perjeta and Herceptin, under the skin in just minutes, compared to hours with intravenous infusion1,2,3 Subcutaneous administration is preferred by patients, physicians and healthcare providers, and can be associated with reduced hospital times and costs4,5,6 This is the first time that Roche... Read more